Skip to content

Clinical trials

Phase 2 Skin Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Diseases Phase: Phase 2 Country / region: Canada Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20112
20121
20132
20161
20172
20184
20193
20211
20226
20232
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting4
Terminated3
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation6
Pfizer4
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's3
Akros Pharma Inc.2
Apollo Therapeutics Ltd2
Inmagene LLC2
Amgen1
Astellas Pharma Global Development, Inc.1
Cogent Biosciences, Inc.1
Deana Funaro1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Diseases33
Eczema11
Dermatitis, Atopic10
Dermatitis8
Psoriasis7
Immune System Diseases6
Hidradenitis Suppurativa5
Connective Tissue Diseases3
Pruritus3
Scleroderma, Diffuse3

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.